327 related articles for article (PubMed ID: 21064091)
1. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
Heymans J; Benoy IH; Poppe W; Depuydt CE
Int J Cancer; 2011 Aug; 129(4):903-9. PubMed ID: 21064091
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
3. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
4. Role of the HPV DNA test in follow-up of treated cervical intraepithelial neoplasia in Bangladesh.
Nessa A; Rashid MH; Jahan M; Ferdous NE; Nahar PA; Chowdhury A
Asian Pac J Cancer Prev; 2014; 15(19):8063-7. PubMed ID: 25338985
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
[TBL] [Abstract][Full Text] [Related]
6. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
7. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
8. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
Zielinski GD; Rozendaal L; Voorhorst FJ; Berkhof J; Snijders PJ; Risse EJ; Runsink AP; de Schipper FA; Meijer CJ
Gynecol Oncol; 2003 Oct; 91(1):67-73. PubMed ID: 14529664
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.
Jeong NH; Lee NW; Kim HJ; Kim T; Lee KW
J Obstet Gynaecol Res; 2009 Aug; 35(4):706-11. PubMed ID: 19751331
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization.
Chao A; Lin CT; Hsueh S; Chou HH; Chang TC; Chen MY; Lai CH
Am J Obstet Gynecol; 2004 Apr; 190(4):1046-51. PubMed ID: 15118639
[TBL] [Abstract][Full Text] [Related]
11. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
Ruano Y; Torrents M; Ferrer FJ
Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
14. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
[TBL] [Abstract][Full Text] [Related]
16. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
18. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
